Yale Jin
Analyst, Laylaw
Replay available
EyePoint, Inc. (EYPT) Q1 2026 Earnings Call
EyePoint, Inc. (NASDAQ: EYPT) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Faisal Khurshid
Analyst, Jefferies
Unknown Participant
Tess Romero
Analyst, JP Morgan
Lisa Walter
Analyst, RBC Capital Markets
Dr. Romero-Ribero
Chief Medical Officer
Citigroup Analyst
Analyst, Citigroup
Michael Campbell
Chief Commercial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Eyepoint, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.658 Okay, and our next question comes from the line of Tess 00:00:04.658 -- 00:00:08.361 Romero with JP Morgan. Our 00:00:11.690 -- 00:00:15.756 next question comes from the line of Tess Romero with JP Morgan. 00:00:15.756 -- 00:00:17.916 Good morning. 00:00:18.240 -- 00:00:22.266 My name is Brittany, and I'll be your conference operator today. 00:00:22.266 -- 00:00:27.919 At this time, I would like to welcome everyone to the iPoint first quarter 2026 financial 00:00:27.919 -- 00:00:30.884 results and recent corporate development conference call. 00:00:30.884 -- 00:00:35.871 There will be a question and answer session to follow the completion of prepared remarks. 00:00:35.871 -- 00:00:40.658 Please be advised that this call is being recorded at the company's request. 00:00:40.658 -- 00:00:46.106 I would now like to turn the call over to George Elston, 00:00:46.106 -- 00:00:51.290 Executive Vice President and Chief Financial Officer of iPoint. 00:00:59.937 -- 00:01:04.404 Thank you, and thank you all for joining us on today's conference call to discuss iPoint's 00:01:04.404 -- 00:01:06.567 first quarter 2026 00:01:06.567 -- 00:01:09.652 financial results and recent corporate developments. 00:01:09.652 -- 00:01:14.459 With me today is Dr. Jay Duker, President and Chief Executive Officer of iPoint. 00:01:14.459 -- 00:01:18.586 Jay will begin with a review of recent corporate updates and discuss our ongoing clinical 00:01:18.586 -- 00:01:22.812 programs for DuraView and WED-AMD and DME. 00:01:22.812 -- 00:01:27.410 I will close with commentary on the first quarter 2026 financial results. 00:01:27.410 -- 00:01:31.157 We will then open the call for your questions, where we will be joined by Dr. 00:01:31.157 -- 00:01:37.865 Romero-Ribero, our...